Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2025Journal of Indira Gandhi Institute Of Medical SciencesOpen Access

Causality assessment of severe and serious adverse events following immunization during measles–rubella vaccination campaign in India: Secondary data analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

NGNidhi GuptaNSNeha SinglaHAHimanshu Arya

Discussion

Loading...

Member takes

Overview

Secondary data analysis identifies high rates of causally associated adverse events after measles-rubella vaccination, suggesting a need for improved management strategies.

Key Points

  • The analysis classified 776 serious/severe adverse events following immunization during the MR vaccination campaign.
  • Out of the assessed cases, 639 (82.3%) were causally associated with the MR vaccination, indicating a significant prevalence of anxiety-related events.
  • The majority of reported adverse events (64%) were found in adolescents aged 10–19 years, highlighting a vulnerable age group.
  • Managing anxiety-related adverse events is crucial to maintaining public trust in vaccination efforts and enhancing immunization coverage.

Cite This Study

Gupta et al. (2025) studied this question.

synapsesocial.com/papers/68dd91cffe798ba2fc498a87https://doi.org/10.4103/jigims.jigims_18_25
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identification and Reporting of Adverse events following Immunization – A Prospective and Observational Study2024
  2. 2Active surveillance of adverse events following immunisation in children: pre, during and post COVID-19 pandemic2026 · 1 citations
  3. 3Understanding adverse events following immunisation: evidence of vaccine safety and coincidental events from 3 years of surveillance2026 · 1 citations
  4. 4A Cross-Sectional Study to Assess the Coverage and Determinants of theMeasles-Rubella Vaccination Campaign in an Urban Field Practice Area2025
  5. 5A PROSPECTIVE OBSERVATIONAL STUDY ON SAFETY EVALUATION OF IMMUNIZATION IN INFANTS AND CHILDREN2024